{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:37:03Z","timestamp":1783111023578,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Swedish Cancer Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.semcancer.2009.10.001","type":"journal-article","created":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T08:26:22Z","timestamp":1256718382000},"page":"407-410","source":"Crossref","is-referenced-by-count":16,"title":["To the genesis of Burkitt lymphoma: Regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes"],"prefix":"10.1016","volume":"19","author":[{"given":"Noemi","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2009.10.001_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev"},{"key":"10.1016\/j.semcancer.2009.10.001_bib2","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/JVI.68.9.6069-6073.1994","article-title":"Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV","volume":"68","author":"Shimizu","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/515290","article-title":"Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype","volume":"177","author":"Chodosh","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semcancer.2009.10.001_bib4","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein-Barr virus provides a survival factor to Burkitt's lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.10.001_bib5","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","article-title":"Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata","volume":"73","author":"Komano","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2009.10.001_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.semcancer.2009.10.001_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM [see comments]","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2009.10.001_bib9","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.10.001_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2009.10.001_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nri1761","article-title":"Immune regulation by SLAM family receptors and SAP-related adaptors","volume":"6","author":"Veillette","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib12","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/intimm\/12.12.1749","article-title":"Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4","volume":"12","author":"Sayos","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2478(01)00330-3","article-title":"SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK","volume":"80","author":"Liu","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.semcancer.2009.10.001_bib14","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.4049\/jimmunol.166.9.5480","article-title":"CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A","volume":"166","author":"Shlapatska","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI200523139","article-title":"Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells","volume":"115","author":"Ma","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semcancer.2009.10.001_bib16","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood-2004-08-3269","article-title":"SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells","volume":"105","author":"Dupre","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.10.001_bib17","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1073\/pnas.131193098","article-title":"Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/SAP","volume":"98","author":"Czar","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.10.001_bib18","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1073\/pnas.0408681102","article-title":"Defective B cell responses in the absence of SH2D1A","volume":"102","author":"Morra","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.10.001_bib19","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood-2004-07-2731","article-title":"Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap","volume":"106","author":"Al-Alem","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.10.001_bib20","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1073\/pnas.130193097","article-title":"The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B","volume":"97","author":"Sylla","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.10.001_bib21","first-page":"4284","article-title":"Cellular immune defects to Epstein-Barr virus-determined antigens in young males","volume":"41","author":"Masucci","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2009.10.001_bib22","first-page":"3118","article-title":"Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.10.001_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0952-7915(99)80072-7","article-title":"The abnormal gene in X-linked lymphoproliferative syndrome","volume":"11","author":"Sullivan","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib24","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1038\/sj.onc.1207908","article-title":"Wild-type p53 activates SAP expression in lymphoid cells","volume":"23","author":"Nagy","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.10.001_bib25","doi-asserted-by":"crossref","first-page":"11966","DOI":"10.1073\/pnas.0905691106","article-title":"The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease","volume":"106","author":"Nagy","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2009.10.001_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/eji.200636417","article-title":"Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death","volume":"37","author":"Chen","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#","article-title":"SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines","volume":"88","author":"Nagy","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semcancer.2009.10.001_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.10498","article-title":"SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation","volume":"100","author":"Nagy","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semcancer.2009.10.001_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1097-0142(19920801)70:3<683::AID-CNCR2820700324>3.0.CO;2-C","article-title":"Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease","volume":"70","author":"Egeler","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2009.10.001_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2141.2000.01884.x","article-title":"Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection","volume":"108","author":"Strahm","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2009.10.001_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1440-1754.1992.tb02639.x","article-title":"Report on the X-linked lymphoproliferative disease in an Australian family","volume":"28","author":"Turner","year":"1992","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.semcancer.2009.10.001_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0140-6736(93)91413-G","article-title":"Correction of Duncan's syndrome by allogeneic bone marrow transplantation","volume":"342","author":"Williams","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2009.10.001_bib33","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1073\/pnas.92.14.6577","article-title":"Persistence of immunoglobulin heavy chain\/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men","volume":"92","author":"Muller","year":"1995","journal-title":"Proc Natl Acad Sci USA,"},{"key":"10.1016\/j.semcancer.2009.10.001_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","article-title":"Induction of apoptosis in fibroblasts by c-myc protein","volume":"69","author":"Evan","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2009.10.001_bib35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2009.10.001_bib36","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.onc.1201702","article-title":"Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells","volume":"16","author":"Capoulade","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2009.10.001_bib37","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/sj.onc.1204303","article-title":"Wiman KG. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53","volume":"20","author":"Lindstrom","year":"2001","journal-title":"Oncogene"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X09000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X09000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T08:35:56Z","timestamp":1590222956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X09000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1044579X09000777"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2009.10.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}